Skip Nav Destination
Issues
1 January 2006
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorials
Review
Human Cancer Biology
Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells
Tanya Gritsko; Ann Williams; James Turkson; Satoshi Kaneko; Tammy Bowman; Mei Huang; Sangkil Nam; Ibrahim Eweis; Nils Diaz; Daniel Sullivan; Sean Yoder; Steve Enkemann; Steven Eschrich; Ji-Hyun Lee; Craig A. Beam; Jin Cheng; Susan Minton; Carlos A. Muro-Cacho; Richard Jove
Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression
Nills Diaz; Susan Minton; Charles Cox; Tammy Bowman; Tanya Gritsko; Roy Garcia; Ibrahim Eweis; Marek Wloch; Sandy Livingston; Ed Seijo; Alan Cantor; Ji-Hyun Lee; Craig A. Beam; Daniel Sullivan; Richard Jove; Carlos A. Muro-Cacho
Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer
Hidekazu Kuramochi; Kazuhiko Hayashi; Kazumi Uchida; Satoru Miyakura; Daisuke Shimizu; Daniel Vallböhmer; Seongjin Park; Kathleen D. Danenberg; Ken Takasaki; Peter V. Danenberg
Detection of Wilms' Tumor Antigen–Specific CTL in Tumor-Draining Lymph Nodes of Patients with Early Breast Cancer
Roopinder Gillmore; Shao-An Xue; Angelika Holler; Jaspal Kaeda; Dimitri Hadjiminas; Vourneen Healy; Roberto Dina; Suzanne C. Parry; Ilaria Bellantuono; Yasmeen Ghani; R. Charles Coombes; Jonathan Waxman; Hans J. Stauss
Detection of EGFR Gene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay
Hiroaki Asano; Shinichi Toyooka; Masaki Tokumo; Kouichi Ichimura; Keisuke Aoe; Sachio Ito; Kazunori Tsukuda; Mamoru Ouchida; Motoi Aoe; Hideki Katayama; Akio Hiraki; Kazuro Sugi; Katsuyuki Kiura; Hiroshi Date; Nobuyoshi Shimizu
Imaging, Diagnosis, Prognosis
Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis
David A. Brown; Carsten Stephan; Robyn L. Ward; Mathew Law; Mark Hunter; Asne R. Bauskin; Janaki Amin; Klaus Jung; Eleftherios P. Diamandis; Garret M. Hampton; Pamela J. Russell; Graham G. Giles; Samuel N. Breit
Value of 18F-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy
Christoph Pöttgen; Sabine Levegrün; Dirk Theegarten; Simone Marnitz; Sara Grehl; Roman Pink; Wilfried Eberhardt; Georgios Stamatis; Thomas Gauler; Gerald Antoch; Andreas Bockisch; Martin Stuschke
Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays
Begoña Comin-Anduix; Antonio Gualberto; John A. Glaspy; Elisabeth Seja; Maribel Ontiveros; Deborah L. Reardon; Roberto Renteria; Brigitte Englahner; James S. Economou; Jesus Gomez-Navarro; Antoni Ribas
Expression of Hepatoma-Derived Growth Factor Is Correlated with Lymph Node Metastasis and Prognosis of Gastric Carcinoma
Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Shuji Takiguchi; Yoshiyuki Fujiwara; Takushi Yasuda; Yuichiro Doki; Kenya Yoshida; Katsuyuki Aozasa; Hideji Nakamura; Morito Monden
Cancer Therapy: Clinical
Cancer Therapy: Preclinical
Anti-CD3 × Anti-Epidermal Growth Factor Receptor (EGFR) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers In vitro and in an Animal Model
Ursula Reusch; Magesh Sundaram; Pamela A. Davol; Sarah D. Olson; James B. Davis; Kurt Demel; Julie Nissim; Ritesh Rathore; Paul Y. Liu; Lawrence G. Lum
Motexafin-Gadolinium Taken Up In vitro by at Least 90% of Glioblastoma Cell Nuclei
Gelsomina De Stasio; Deepika Rajesh; Judith M. Ford; Matthew J. Daniels; Robert J. Erhardt; Bradley H. Frazer; Tolek Tyliszczak; Mary K. Gilles; Robert L. Conhaim; Steven P. Howard; John F. Fowler; François Estève; Minesh P. Mehta
Evaluation of the Antitumor Efficacy, Pharmacokinetics, and Pharmacodynamics of the Histone Deacetylase Inhibitor Depsipeptide in Childhood Cancer Models In vivo
Claire Graham; Chandra Tucker; Jeremy Creech; Edward Favours; Catherine A. Billups; Tiebin Liu; Maryam Fouladi; Burgess B. Freeman, III; Clinton F. Stewart; Peter J. Houghton
Antitumor Efficacy of a Combination of CMC-544 (Inotuzumab Ozogamicin), a CD22-Targeted Cytotoxic Immunoconjugate of Calicheamicin, and Rituximab against Non-Hodgkin's B-Cell Lymphoma
John F. DiJoseph; Maureen M. Dougher; Lyka B. Kalyandrug; Douglas C. Armellino; Erwin R. Boghaert; Philip R. Hamann; Justin K. Moran; Nitin K. Damle
Optimizing a Novel Regional Chemotherapeutic Agent against Melanoma: Hyperthermia-Induced Enhancement of Temozolomide Cytotoxicity
Sae Hee Ko; Tomio Ueno; Yasunori Yoshimoto; Jin Soo Yoo; Omar I. Abdel-Wahab; Zeinab Abdel-Wahab; Edward Chu; Scott K. Pruitt; Henry S. Friedman; Mark W. Dewhirst; Douglas S. Tyler
Cancer Prevention
Letter to the Editor
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds